METHODS: We present a mini review to discuss the role of stereotactic biopsy in the context of novel developments in diagnostics for PCNSL, as well as the role for cytoreductive surgery.
RESULTS: Cerebrospinal fluid-based diagnostics are supplementary and cannot replace stereotactic biopsy-based diagnostics.
CONCLUSIONS: Histopathological diagnosis after stereotactic biopsy of the brain remains the gold standard for diagnosis. Additional diagnostics should not be a cause of diagnostic delay. There is currently no sufficient evidence supporting cytoreductive surgery in PCNSL, with recent studies showing contradictive data and suboptimal study designs.
方法:我们提出了一个小型综述,以讨论立体定向活检在PCNSL诊断新发展的背景下的作用。以及细胞减灭术的作用。
结果:基于脑脊液的诊断是辅助诊断,不能取代基于立体定向活检的诊断。
结论:脑立体定向活检后的组织病理学诊断仍然是诊断的金标准。额外的诊断不应是诊断延迟的原因。目前没有足够的证据支持PCNSL的细胞减灭术,最近的研究显示矛盾的数据和次优的研究设计。